BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22661450)

  • 21. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study.
    Saeed K; Wilson DC; Bloos F; Schuetz P; van der Does Y; Melander O; Hausfater P; Legramante JM; Claessens YE; Amin D; Rosenqvist M; White G; Mueller B; Limper M; Callejo CC; Brandi A; Macchi MA; Cortes N; Kutz A; Patka P; Yañez MC; Bernardini S; Beau N; Dryden M; van Gorp ECM; Minieri M; Chan L; Rood PPM; Del Castillo JG
    Crit Care; 2019 Feb; 23(1):40. PubMed ID: 30736862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary Proadrenomedullin and Disease Severity in Children With Suspected Community-acquired Pneumonia.
    Florin TA; Ambroggio L; Shah SS; Ruddy RM; Nylen ES; Balmert L
    Pediatr Infect Dis J; 2021 Dec; 40(12):1070-1075. PubMed ID: 34533488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proadrenomedullin Predicts Severe Disease in Children With Suspected Community-acquired Pneumonia.
    Florin TA; Ambroggio L; Brokamp C; Zhang Y; Nylen ES; Rattan M; Crotty E; Belsky MA; Krueger S; Epperson TN; Kachelmeyer A; Ruddy RM; Shah SS
    Clin Infect Dis; 2021 Aug; 73(3):e524-e530. PubMed ID: 32761072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does mid-regional pro-adrenomedullin (MR-proADM) improve the sequential organ failure assessment-score (SOFA score) for mortality-prediction in patients with acute infections? Results of a prospective observational study.
    Haag E; Gregoriano C; Molitor A; Kloter M; Kutz A; Mueller B; Schuetz P
    Clin Chem Lab Med; 2021 May; 59(6):1165-1176. PubMed ID: 33554514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19.
    Roedl K; Jarczak D; Fischer M; Haddad M; Boenisch O; de Heer G; Burdelski C; Frings D; Sensen B; Karakas M; Kluge S; Nierhaus A
    Biomarkers; 2021 Jul; 26(5):417-424. PubMed ID: 33754916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mid-regional pro-adrenomedullin predicts poor outcome in non-selected patients admitted to an intensive care unit.
    Bellia C; Agnello L; Lo Sasso B; Bivona G; Raineri MS; Giarratano A; Ciaccio M
    Clin Chem Lab Med; 2019 Mar; 57(4):549-555. PubMed ID: 30157027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midregional proadrenomedullin safely reduces hospitalization in a low severity cohort with infections in the ED: a randomized controlled multi-centre interventional pilot study.
    Gonzalez Del Castillo J; Clemente-Callejo C; Llopis F; Irimia A; Oltra-Hostalet F; Rechner C; Schwabe A; Fernandez-Rodriguez V; Sánchez-Mora C; Giol-Amich J; Prieto-García B; Bardés-Robles I; Ortega-de Heredia MD; García-Lamberechts EJ; Navarro-Bustos C;
    Eur J Intern Med; 2021 Jun; 88():104-113. PubMed ID: 33906810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma Levels of Mid-Regional Proadrenomedullin Accurately Identify H1N1pdm09 Influenza Virus Patients with Risk of Intensive Care Admission and Mortality in the Emergency Department.
    Valenzuela-Méndez B; Valenzuela-Sánchez F; Rodríguez-Gutiérrez JF; Bohollo-de-Austria R; Estella Á; Martínez-García P; González-García MÁ; Rello J
    J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum High-Sensitivity C Reactive Protein Improves Sensitivity of CURB-65 in Predicting ICU Admission and Mortality in Community-Acquired Pneumonia Patients.
    Ge YL; Liu CH; Xu J; Cui ZY; Guo WC; Li HL; Fu AS; Wang HY; Zhang HF; Zhu XY
    Clin Lab; 2018 Oct; 64(10):1749-1754. PubMed ID: 30336524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of proadrenomedullin as a diagnostic or prognostic biomarker of acute appendicitis in children.
    Míguez C; Tomatis Souverbielle C; Haro A; Guerrero G; Pérez-Egido L; García-Gamiz M; Marañon R
    Am J Emerg Med; 2016 Dec; 34(12):2298-2305. PubMed ID: 27609121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR-proADM as marker of endotheliitis predicts COVID-19 severity.
    García de Guadiana-Romualdo L; Calvo Nieves MD; Rodríguez Mulero MD; Calcerrada Alises I; Hernández Olivo M; Trapiello Fernández W; González Morales M; Bolado Jiménez C; Albaladejo-Otón MD; Fernández Ovalle H; Conesa Hernández A; Azpeleta Manrique E; Consuegra-Sánchez L; Nogales Martín L; Conesa Zamora P; Andaluz-Ojeda D
    Eur J Clin Invest; 2021 May; 51(5):e13511. PubMed ID: 33569769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity of SMART-COP score in prognosis and severity of community acquired pneumonia in the emergency department.
    Ehsanpoor B; Vahidi E; Seyedhosseini J; Jahanshir A
    Am J Emerg Med; 2019 Aug; 37(8):1450-1454. PubMed ID: 30401592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting the need for ICU admission in community-acquired pneumonia.
    Gearhart AM; Furmanek S; English C; Ramirez J; Cavallazzi R
    Respir Med; 2019 Aug; 155():61-65. PubMed ID: 31302580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study.
    Graziadio S; O'Leary RA; Stocken DD; Power M; Allen AJ; Simpson AJ; Price DA
    BMJ Open; 2019 Feb; 8(11):e020337. PubMed ID: 30798282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable State Proadrenomedullin Level in COPD Patients: A Validation Study.
    Zuur-Telgen M; VanderValk P; van der Palen J; Kerstjens HA; Brusse-Keizer M
    COPD; 2017 Apr; 14(2):219-227. PubMed ID: 27880050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procalcitonin (PCT) Improves the Accuracy and Sensitivity of CURB-65 Score in Predicting CAP Patients Admission to ICU.
    Liu JX; Zhang Q; Bai JS; Wang JM; Liu RX; Zhou XY; Gao S; Chen QC; Zhang JB; Fu AS; Ge YL
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of the CURB-65 Score in Predicting Critical Care Interventions in Patients Admitted With Community-Acquired Pneumonia.
    Ilg A; Moskowitz A; Konanki V; Patel PV; Chase M; Grossestreuer AV; Donnino MW
    Ann Emerg Med; 2019 Jul; 74(1):60-68. PubMed ID: 30078659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity paradox in patients with community-acquired pneumonia: Is inflammation the missing link?
    Braun N; Hoess C; Kutz A; Christ-Crain M; Thomann R; Henzen C; Zimmerli W; Mueller B; Schuetz P
    Nutrition; 2017 Jan; 33():304-310. PubMed ID: 27742103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study.
    Atallah NJ; Panossian VS; Atallah CJ; Schwabe A; Johannes S; Wiemer J; Mansour MK
    Open Forum Infect Dis; 2022 Sep; 9(9):ofac423. PubMed ID: 36072696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia.
    Uranga A; Artaraz A; Bilbao A; Quintana JM; Arriaga I; Intxausti M; Lobo JL; García JA; Camino J; España PP
    BMC Pulm Med; 2020 Oct; 20(1):261. PubMed ID: 33028293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.